in vivo-jetPEI® reagent provides versatile, reproducible and reliable delivery of all types of nucleic acids (DNA, siRNA, miRNA and more) in animal models, for functional studies and RNA interference experiments using various administration routes.
- Suitable for in vivo delivery of any nucleic acid
- Proven track record: Cited in over 700 publications
- Very easy to use: Two-step protocol
- Used for therapeutics and clinical trials worldwide
- Safe: No inflammatory response triggered
- Protocols tailored for your application by Polyplus-transfection® delivery experts
in vivo-jetPEI® eignet sich besonders als Transfersubstanz für Therapie-Ansätze, z. B. Gentherapie, genetische Immunisierung, Immuntherapie und Krebsbehandlung.
Since 1st of September 2021 Polyplus-Tranfection changed product part numbers. Products are remaining the same and the change is only related to the product part number. New product part numbers have symbol 'New'. For duplicated products with symbol 'telephone' please be informed that it’s the same product but with previous part number which we will only offer till the end of stock.
Zertifizierungen: Polyplus-transfection® has been an ISO 9001 accredited company since 2002. Since then this certification has been successfully renewed every three years.
Each lot of in vivo-jetPEI® is validated by DNA (pCMV-Luciferase) delivery into mouse through intravenous injection. The amount of luciferase (ng) per mg of protein is indicated on the Certificate of Analysis for each lot of reagent. Moreover, absence of endotoxin is verified in every lot of in vivo-jetPEI®.
Lieferumfang: 10% Glucose-Lösung ist im Umfang enthalten. 0,1 ml in vivo-jetPEI™ Transferreagenz reicht für bis zu 20 intravenöse Injektionen in Mäusen mit 50 µg DNA aus.
